• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组中碳水化合物代谢基因的耗竭导致从中心性肥胖向 2 型糖尿病的转变。

The Depletion of Carbohydrate Metabolic Genes in the Gut Microbiome Contributes to the Transition From Central Obesity to Type 2 Diabetes.

机构信息

GENEWIZ Inc., Suzhou, China.

Department of General Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.

出版信息

Front Endocrinol (Lausanne). 2021 Oct 22;12:747646. doi: 10.3389/fendo.2021.747646. eCollection 2021.

DOI:10.3389/fendo.2021.747646
PMID:34745012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8569854/
Abstract

Obesity, especially central obesity, is a strong risk factor for developing type 2 diabetes (T2D). However, the mechanism underlying the progression from central obesity to T2D remains unknown. Therefore, we analyzed the gut microbial profiles of central obese individuals with or without T2D from a Chinese population. Here we reported both the microbial compositional and gene functional alterations during the progression from central obesity to T2D. Several opportunistic pathogens were enriched in obese T2D patients. We also characterized thousands of genes involved in sugar and amino acid metabolism whose abundance were significantly depleted in obese T2D group. Moreover, the abundance of those genes was negatively associated with plasma glycemia level and percentage of individuals with impaired plasma glucose status. Therefore, our study indicates that the abundance of those depleted genes can be used as a potential biomarker to identify central obese individuals with high risks of developing T2D.

摘要

肥胖,尤其是中心型肥胖,是 2 型糖尿病(T2D)发生的一个强烈危险因素。然而,从中心型肥胖进展到 T2D 的机制尚不清楚。因此,我们分析了来自中国人群的伴或不伴 T2D 的中心型肥胖个体的肠道微生物特征。在此,我们报道了从中型肥胖进展到 T2D 过程中微生物组成和功能的变化。在肥胖 T2D 患者中,几种机会性病原体被富集。我们还鉴定了数千个参与糖和氨基酸代谢的基因,其在肥胖 T2D 组中的丰度明显减少。此外,这些基因的丰度与血浆血糖水平和糖代谢受损个体的比例呈负相关。因此,我们的研究表明,这些减少的基因的丰度可用作识别具有发展为 T2D 高风险的中心型肥胖个体的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/d0868709658e/fendo-12-747646-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/b86526dde8a6/fendo-12-747646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/0cf4c0dc247d/fendo-12-747646-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/8f6e93d49002/fendo-12-747646-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/432ba4c23e79/fendo-12-747646-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/d0868709658e/fendo-12-747646-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/b86526dde8a6/fendo-12-747646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/0cf4c0dc247d/fendo-12-747646-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/8f6e93d49002/fendo-12-747646-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/432ba4c23e79/fendo-12-747646-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f399/8569854/d0868709658e/fendo-12-747646-g005.jpg

相似文献

1
The Depletion of Carbohydrate Metabolic Genes in the Gut Microbiome Contributes to the Transition From Central Obesity to Type 2 Diabetes.肠道微生物组中碳水化合物代谢基因的耗竭导致从中心性肥胖向 2 型糖尿病的转变。
Front Endocrinol (Lausanne). 2021 Oct 22;12:747646. doi: 10.3389/fendo.2021.747646. eCollection 2021.
2
Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.分析生活在同一地理区域的两种族裔背景个体的肠道微生物组与 2 型糖尿病的关联。
Nutrients. 2021 Sep 21;13(9):3289. doi: 10.3390/nu13093289.
3
Implication of the gut microbiome composition of type 2 diabetic patients from northern China.中国北方 2 型糖尿病患者肠道微生物组成的意义。
Sci Rep. 2020 Mar 25;10(1):5450. doi: 10.1038/s41598-020-62224-3.
4
Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.丹麦和印度的跨种族 2 型糖尿病肠道微生物群特征。
Genome Med. 2021 Mar 3;13(1):37. doi: 10.1186/s13073-021-00856-4.
5
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.解析人类肠道微生物群中的2型糖尿病和二甲双胍治疗特征。
Nature. 2015 Dec 10;528(7581):262-266. doi: 10.1038/nature15766. Epub 2015 Dec 2.
6
Gut microbiome and type 2 diabetes: where we are and where to go?肠道微生物组与 2 型糖尿病:我们在哪里,以及我们要往哪里去?
J Nutr Biochem. 2019 Jan;63:101-108. doi: 10.1016/j.jnutbio.2018.10.003. Epub 2018 Oct 11.
7
Unique Gut Microbiome Signatures Depict Diet-Versus Genetically Induced Obesity in Mice.独特的肠道微生物组特征描绘了小鼠饮食与遗传诱导肥胖。
Int J Mol Sci. 2020 May 13;21(10):3434. doi: 10.3390/ijms21103434.
8
Plasma sphingolipids mediate the association between gut microbiome composition and type 2 diabetes risk in the HELIUS cohort: a case-cohort study.血浆神经酰胺介导肠道微生物群组成与 HELIUS 队列 2 型糖尿病风险之间的关联:病例-队列研究。
BMJ Open Diabetes Res Care. 2024 Jul 18;12(4):e004180. doi: 10.1136/bmjdrc-2024-004180.
9
Construction and Analysis of Functional Networks in the Gut Microbiome of Type 2 Diabetes Patients.2型糖尿病患者肠道微生物群功能网络的构建与分析
Genomics Proteomics Bioinformatics. 2016 Oct;14(5):314-324. doi: 10.1016/j.gpb.2016.02.005. Epub 2016 Oct 14.
10
The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.肠道微生物组与多种族队列中的 2 型糖尿病状态。
PLoS One. 2021 Jun 23;16(6):e0250855. doi: 10.1371/journal.pone.0250855. eCollection 2021.

引用本文的文献

1
Spatial variations in the microbiota: comparative analysis of microbial composition and predicted functions across different intestinal segments and feces in donkeys.微生物群的空间变异:驴不同肠道段和粪便中微生物组成及预测功能的比较分析
Front Microbiol. 2025 Jan 17;15:1494926. doi: 10.3389/fmicb.2024.1494926. eCollection 2024.
2
Gender Differences of Visceral Fat Area to Hip Circumference Ratio for Insulin Resistance.胰岛素抵抗的内脏脂肪面积与臀围比值的性别差异
Diabetes Metab Syndr Obes. 2024 Oct 22;17:3935-3942. doi: 10.2147/DMSO.S482820. eCollection 2024.
3
Metagenomic functional profiling: to sketch or not to sketch?

本文引用的文献

1
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations.中国卒中报告 2019:国家医疗质量管理与控制中心神经系统疾病专家委员会,国家神经系统疾病临床医学研究中心,中国卒中学会,国家心血管病中心,中国疾病预防控制中心,全球神经科学与卒中协作组织联合报告。
Stroke Vasc Neurol. 2020 Sep;5(3):211-239. doi: 10.1136/svn-2020-000457. Epub 2020 Aug 21.
2
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study.基于人群的横断面研究:糖尿病前期和糖尿病中的肠道微生物群。
Cell Metab. 2020 Sep 1;32(3):379-390.e3. doi: 10.1016/j.cmet.2020.06.011. Epub 2020 Jul 10.
3
宏基因组功能谱分析:描绘还是不描绘?
Bioinformatics. 2024 Sep 1;40(Suppl 2):ii165-ii173. doi: 10.1093/bioinformatics/btae397.
4
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.接受者微生物组相关特征预测肥胖合并代谢综合征成人接受粪便微生物群移植后代谢改善:一项 2 期临床试验的二次分析。
Gut Microbes. 2024 Jan-Dec;16(1):2345134. doi: 10.1080/19490976.2024.2345134. Epub 2024 Apr 29.
5
Impact of Season on Intestinal Bacterial Communities and Pathogenic Diversity in Two Captive Duck Species.季节对两种圈养鸭肠道细菌群落及致病多样性的影响
Animals (Basel). 2023 Dec 16;13(24):3879. doi: 10.3390/ani13243879.
6
Differences in Gut Microbiota between Healthy Individuals and Patients with Perianal Abscess before and after Surgery.健康个体与肛周脓肿患者手术前后肠道微生物组的差异。
Mediators Inflamm. 2023 Apr 12;2023:1165916. doi: 10.1155/2023/1165916. eCollection 2023.
7
Anti-diabetic prospects of dietary bio-actives of millets and the significance of the gut microbiota: A case of finger millet.粟类膳食生物活性成分的抗糖尿病前景及肠道微生物群的意义:以龙爪稷为例
Front Nutr. 2022 Dec 22;9:1056445. doi: 10.3389/fnut.2022.1056445. eCollection 2022.
8
Gut microbial response to host metabolic phenotypes.肠道微生物对宿主代谢表型的反应。
Front Nutr. 2022 Nov 7;9:1019430. doi: 10.3389/fnut.2022.1019430. eCollection 2022.
9
Aqueous Extract of Guava ( L.) Leaf Ameliorates Hyperglycemia by Promoting Hepatic Glycogen Synthesis and Modulating Gut Microbiota.番石榴叶水提取物通过促进肝糖原合成和调节肠道微生物群来改善高血糖。
Front Pharmacol. 2022 Jun 1;13:907702. doi: 10.3389/fphar.2022.907702. eCollection 2022.
Role of gut microbiota in type 2 diabetes pathophysiology.肠道微生物群在 2 型糖尿病发病机制中的作用。
EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3.
4
Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition.肥胖个体(无论是否患有 2 型糖尿病)表现出不同的肠道微生物功能能力和组成。
Cell Host Microbe. 2019 Aug 14;26(2):252-264.e10. doi: 10.1016/j.chom.2019.07.004. Epub 2019 Aug 6.
5
The role of short-chain fatty acids in microbiota-gut-brain communication.短链脂肪酸在肠道菌群-肠-脑通讯中的作用。
Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):461-478. doi: 10.1038/s41575-019-0157-3.
6
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.肠道微生物组、短链脂肪酸与代谢性疾病之间的因果关系。
Nat Genet. 2019 Apr;51(4):600-605. doi: 10.1038/s41588-019-0350-x. Epub 2019 Feb 18.
7
Obesity and diabetes-Not only a simple link between two epidemics.肥胖与糖尿病——不仅仅是两种流行病之间的简单关联。
Diabetes Metab Res Rev. 2018 Oct;34(7):e3042. doi: 10.1002/dmrr.3042. Epub 2018 Jul 17.
8
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery.严重肥胖症中的主要微生物失调:减肥手术后的命运。
Gut. 2019 Jan;68(1):70-82. doi: 10.1136/gutjnl-2018-316103. Epub 2018 Jun 13.
9
Role of the gut microbiota in nutrition and health.肠道微生物群在营养与健康中的作用。
BMJ. 2018 Jun 13;361:k2179. doi: 10.1136/bmj.k2179.
10
A high-sugar diet affects cellular and humoral immune responses in Drosophila.高糖饮食会影响果蝇的细胞和体液免疫反应。
Exp Cell Res. 2018 Jul 15;368(2):215-224. doi: 10.1016/j.yexcr.2018.04.032. Epub 2018 May 1.